Open in web browser

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

TODAY'S HEADLINES

[BLOG]: Sepsis: 4 things formulary managers can do to save lives, resources

By Mike Abrams
Sepsis is the single most expensive condition treated in US hospitals. There are actions formulary managers and every healthcare professional can take to reduce this difficult condition. 4 action items

FDA expands pediatric age indication for Promacta

By Erin Bastick
FDA has expanded approval of eltrombopag (Promacta, Novartis) to treat children aged 1 year and older with chronic immune thrombocytopenic purpura (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Read more

CONTINUING EDUCATION

Primer on inhalers and nebulizers

This month's CE activity is part of the CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss the various types of inhaled devices and educate pharmacists on the techniques for correct device use.

To read and print the article with TEST QUESTIONS, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT33-FTX29.

The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php.
All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce

EDITOR'S PICK

Top 4 future impacts of 3D printed drugs

by Christine Blank
FDA's approval of the first 3D-printed pill — Spritam to control epileptic seizures — will have a major impact on the medical and pharmaceutical community as a whole. FormularyWatch's top predictions

August 28, 2015

Related Articles

Read more FormularyWatch Blogs

Promacta stimulates platelet production in cITP pediatric patients

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click here to contact Editorial. Sales, Reprints, Classified questions? Click here to contact the Sales Team.

ModernMedicine logo
UBM  logo

UBM MEDICA